Switzerland · Delayed Price · Currency is CHF Cosmo Pharmaceuticals Statistics
Total Valuation
SWX:COPN has a market cap or net worth of CHF 1.46 billion. The enterprise value is 1.36 billion.
| Market Cap | 1.46B |
| Enterprise Value | 1.36B |
Important Dates
The last earnings date was Monday, March 9, 2026.
| Earnings Date | Mar 9, 2026 |
| Ex-Dividend Date | Apr 24, 2026 |
Share Statistics
SWX:COPN has 16.19 million shares outstanding. The number of shares has decreased by -2.73% in one year.
| Current Share Class | 16.19M |
| Shares Outstanding | 16.19M |
| Shares Change (YoY) | -2.73% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 21.36% |
| Float | 8.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 1,311.08 |
| PS Ratio | 15.07 |
| PB Ratio | 3.21 |
| P/TBV Ratio | 5.19 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 250.64, with an EV/FCF ratio of -87.41.
| EV / Earnings | -404.31 |
| EV / Sales | 14.00 |
| EV / EBITDA | 250.64 |
| EV / EBIT | n/a |
| EV / FCF | -87.41 |
Financial Position
The company has a current ratio of 7.18, with a Debt / Equity ratio of 0.01.
| Current Ratio | 7.18 |
| Quick Ratio | 5.80 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.73 |
| Debt / FCF | -0.26 |
| Interest Coverage | -57.80 |
Financial Efficiency
Return on equity (ROE) is -0.70% and return on invested capital (ROIC) is -1.87%.
| Return on Equity (ROE) | -0.70% |
| Return on Assets (ROA) | -0.69% |
| Return on Invested Capital (ROIC) | -1.87% |
| Return on Capital Employed (ROCE) | -1.18% |
| Weighted Average Cost of Capital (WACC) | 12.11% |
| Revenue Per Employee | 292,133 |
| Profits Per Employee | -10,118 |
| Employee Count | 332 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 4.48 |
Taxes
In the past 12 months, SWX:COPN has paid 2.39 million in taxes.
| Income Tax | 2.39M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +71.67% in the last 52 weeks. The beta is 1.43, so SWX:COPN's price volatility has been higher than the market average.
| Beta (5Y) | 1.43 |
| 52-Week Price Change | +71.67% |
| 50-Day Moving Average | 112.30 |
| 200-Day Moving Average | 77.68 |
| Relative Strength Index (RSI) | 24.87 |
| Average Volume (20 Days) | 41,005 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SWX:COPN had revenue of CHF 96.99 million and -3.36 million in losses. Loss per share was -0.21.
| Revenue | 96.99M |
| Gross Profit | 47.07M |
| Operating Income | -6.46M |
| Pretax Income | -854,677 |
| Net Income | -3.36M |
| EBITDA | 4.71M |
| EBIT | -6.46M |
| Loss Per Share | -0.21 |
Balance Sheet
The company has 114.29 million in cash and 3.97 million in debt, with a net cash position of 110.32 million or 6.81 per share.
| Cash & Cash Equivalents | 114.29M |
| Total Debt | 3.97M |
| Net Cash | 110.32M |
| Net Cash Per Share | 6.81 |
| Equity (Book Value) | 455.44M |
| Book Value Per Share | 27.73 |
| Working Capital | 146.87M |
Cash Flow
In the last 12 months, operating cash flow was -11.62 million and capital expenditures -3.91 million, giving a free cash flow of -15.54 million.
| Operating Cash Flow | -11.62M |
| Capital Expenditures | -3.91M |
| Free Cash Flow | -15.54M |
| FCF Per Share | -0.96 |
Margins
Gross margin is 48.53%, with operating and profit margins of -6.66% and -3.46%.
| Gross Margin | 48.53% |
| Operating Margin | -6.66% |
| Pretax Margin | -0.88% |
| Profit Margin | -3.46% |
| EBITDA Margin | 4.86% |
| EBIT Margin | -6.66% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.90, which amounts to a dividend yield of 2.02%.
| Dividend Per Share | 1.90 |
| Dividend Yield | 2.02% |
| Dividend Growth (YoY) | -1.09% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.73% |
| Shareholder Yield | 4.75% |
| Earnings Yield | -0.23% |
| FCF Yield | -1.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SWX:COPN has an Altman Z-Score of 6.5 and a Piotroski F-Score of 2.
| Altman Z-Score | 6.5 |
| Piotroski F-Score | 2 |